FOXO3 rs9442890: Longevity and Healthspan Associations
The rs9442890 variant is a noncoding single-nucleotide polymorphism located within the FOXO3 gene, which is widely recognized for its role in human longevity. Research suggests this specific variant may influence survival probability past the age of 85 through complex epistatic interactions.
What each genotype means
Typical longevity baseline
You carry two copies of the common C allele for this noncoding FOXO3 variant. In population studies evaluating survival past age 85, this genotype represents the standard baseline and is not linked to the epistatic survival advantages observed with the alternate allele. Lifestyle, metabolic health, and general environment remain the dominant determinants of your personal healthspan.
Carried by approximately 45% to 50% of individuals of European descent and is common globally.
Moderate longevity interaction
You carry one copy of the T allele for the FOXO3 variant rs9442890. Research in longevity cohorts indicates that this allele may participate in epistatic gene-gene interactions that modestly enhance the likelihood of healthy aging and reaching exceptional ages. However, because these effects are dependent on broader genetic context and environmental factors, carrying this allele does not guarantee extended lifespan.
Carried by roughly 40% to 45% of individuals of European ancestry.
Enhanced longevity interaction
You carry two copies of the less common T allele for rs9442890 in the FOXO3 gene. Research into human aging models suggests this genotype is statistically enriched in cohorts surviving past age 85 through interactive polygenic effects on cellular stress resilience. While associated with favorable survival statistics in observational studies, individual health outcomes depend primarily on comprehensive cardiovascular and metabolic lifestyle habits.
Carried by approximately 9% to 10% of individuals of European ancestry.
Understanding the rs9442890 Variant
The rs9442890 variant is a single-nucleotide polymorphism (SNP) situated within the FOXO3 gene on chromosome 6. Unlike variants that alter the protein-coding sequence of a gene, rs9442890 is located in a noncoding region. This means it does not change the structure of the FOXO3 protein itself, but rather may influence how the gene is regulated, such as when, where, or how much of the protein is produced. In genomics, noncoding variants are often found in regulatory elements like enhancers or promoters, which act as switches for gene expression. Because this variant is part of the FOXO3 locus—a region consistently linked to healthy aging—researchers study it to understand how subtle differences in gene regulation contribute to the biological processes of aging and the attainment of extreme old age.
The Role of the FOXO3 Gene
The FOXO3 gene encodes the forkhead box O3 protein, a transcription factor that acts as a master regulator in several cellular pathways. It is a key component of the insulin/insulin-like growth factor signaling (IIS) pathway, which is evolutionarily conserved across many species, including worms, flies, and humans. By sensing nutrient availability and cellular stress, FOXO3 helps coordinate responses such as DNA repair, apoptosis, and the management of oxidative stress. When active, the protein helps cells maintain homeostasis and resist damage, which is thought to be critical for healthy aging. Because of its central role in these protective mechanisms, variations in the FOXO3 gene are frequently investigated for their potential to influence lifespan and the risk of age-related diseases, making it one of the most studied genes in the field of longevity research.
Research and Evidence Strength
The association between FOXO3 and longevity is supported by multiple studies across diverse populations. While several SNPs in the FOXO3 region have been identified as having strong links to extreme longevity, rs9442890 is considered a lesser-known variant with moderate evidence. Research indicates that its impact on survival is likely not isolated but rather involves epistatic interactions—where the effect of one gene is dependent on the presence of one or more other modifier genes. While some studies have successfully replicated associations between FOXO3 variants and survival past age 85, the exact mechanisms for rs9442890 remain under investigation. It is important to note that genetic associations with longevity are complex and multifactorial, meaning that no single variant acts as a definitive 'longevity switch.' Current evidence suggests that while this variant is a marker of interest, it is part of a broader, intricate genetic landscape that influences human healthspan.
Population Frequency
The rs9442890 variant is present across various human populations, though its frequency can differ significantly based on ancestral background. According to data from the gnomAD database, the minor allele frequency for this variant is approximately 0.31 in European populations. This indicates that the variant is relatively common, rather than rare, within this demographic. Because frequency data can vary by ancestry, researchers often look at large-scale genomic datasets to ensure that findings are consistent across different groups. Understanding these frequencies is essential for scientists to determine whether a genetic association is universal or specific to certain populations. As with many longevity-associated variants, the distribution of these alleles is a subject of ongoing study to better understand the evolutionary history and the potential health implications for diverse groups of people.
Interpreting Your Genetic Information
If you have information about your genotype for rs9442890, it is important to view it within the context of current scientific understanding. Genetic variants associated with longevity are statistical markers observed in large populations; they are not diagnostic tools and cannot predict an individual's lifespan or health outcomes. Many factors, including lifestyle, environment, and the cumulative effect of thousands of other genetic variants, play a much larger role in determining health and longevity than any single SNP. This information is intended for educational purposes and should not be used to make medical decisions or health assumptions. If you have concerns about your health, family history, or how genetics might influence your well-being, the best course of action is to consult with a qualified healthcare provider or a genetic counselor who can provide personalized guidance based on your complete clinical picture.
How common is this variant?
The minor allele frequency for rs9442890 is approximately 0.31 in European populations according to gnomAD data.
Frequently asked questions
Does having the 'longevity' genotype guarantee a long life?
No. Genetic variants like those in FOXO3 are associated with statistical trends in large populations, not individual outcomes. Longevity is influenced by a complex combination of genetics, environment, and lifestyle choices.
Can I use this SNP to predict my risk of disease?
No. This variant is a marker for longevity research and is not a diagnostic tool for predicting disease risk. You should never use genetic information to make medical decisions without consulting a healthcare professional.
What does it mean that this variant is 'noncoding'?
A noncoding variant is located in a part of the DNA that does not provide instructions for making a protein. Instead, these variants often sit in regulatory regions that control how much of a protein is produced by the cell.
Why is FOXO3 called a 'longevity gene'?
FOXO3 is involved in essential cellular processes like DNA repair and stress resistance. Because it helps cells maintain health and function, variations in this gene have been consistently linked to healthy aging in diverse human populations.
Sources & further reading
Educational information only, last refreshed 10/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9442890?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FOXO3
Functional non-coding variant in the key longevity regulator FOXO3 contributing to extended survival and healthspan.
Well-characterized non-headline FOXO3 variant associated with healthy aging, lower cardiovascular mortality, and survival beyond age 90.
Non-coding FOXO3 variant identified in longitudinal aging studies as conferring an advantage for survival from midlife into advanced old age.
Common upstream intronic regulatory variant in FOXO3 correlated with human longevity and enhanced resilience against metabolic disease.
An intronic variant in the FOXO3 gene consistently associated with human longevity and survival to extreme old age across multiple ethnic cohorts.
Intronic variant in FOXO3 significantly associated with exceptional longevity and survival to advanced old age, showing allele-dependent enhancer activity.